anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
AstraZeneca · conference-presentation

AstraZeneca | Investor Day Presentation Deck | 40 slides

40 pages · 4 arc beats · 2 loops

Conference-Presentation Download JSON
Unlock

AstraZeneca | Investor Day Presentation Deck | 40 slides

AstraZeneca · 2021-06
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 40 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Attention 3 slides 100% 3/3 slides 100% 3/3 slides · 15 hits
— 0/3 slides
33.3% 1/3 slides
— 0/3 slides
100% 3/3 slides
— 0/3 slides
Need 3 slides 100% 3/3 slides 100% 3/3 slides · 19 hits
— 0/3 slides
100% 3/3 slides 66.7% 2/3 slides 100% 3/3 slides 100% 3/3 slides Satisfaction 14 slides 100% 14/14 slides 100% 14/14 slides · 85 hits
— 0/14 slides
57.1% 8/14 slides 50% 7/14 slides 100% 14/14 slides 28.6% 4/14 slides Action 20 slides 100% 20/20 slides 100% 20/20 slides · 112 hits
— 0/20 slides
30% 6/20 slides · 7 hits 25% 5/20 slides 100% 20/20 slides 40% 8/20 slides

Slide inventory

40
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
02
other
Open slide detailBeat · Attention
03
The slide uses a central image of a patient/medical team to humanize the strategic pillars.summarize
Open slide detailBeat · Attention
04
The slide uses a column-based layout to segment the portfolio by therapeutic area.summarize
Open slide detailBeat · NeedLoop · Pattern Hunter
05
The slide uses a consistent color-coding for regions: US (dark blue), Europe (magenta), Established Rest of World (yellow), Emerging markets (green).analyze_data
Open slide detailBeat · NeedLoop · Pattern Hunter
06
The slide uses a circular timeline graphic to emphasize the 3rd consecutive plenary session achievement.summarize
Open slide detailBeat · NeedLoop · Pattern Hunter
07
front_matter
Open slide detailBeat · SatisfactionLoop · Pattern Hunter
08
front_matter
Open slide detailBeat · SatisfactionLoop · Pattern Hunter
09
The slide uses a three-pillar framework to organize the strategic approach to lung cancer care.summarize
Open slide detailBeat · SatisfactionLoop · Pattern Hunter
10
Includes a Kaplan-Meier survival curve and a bar chart showing patient reach growth.summarize
Open slide detailBeat · SatisfactionLoop · Pattern Hunter
11
The slide uses a color-coded legend to distinguish between approved indications and ongoing trials across the disease continuum.plan_implementation
Open slide detailBeat · Satisfaction
12
Slide presents two distinct drug portfolios with corresponding clinical trial results (DESTINY-Lung01 and TROPION-PanTumor01).analyze_data
Open slide detailBeat · Satisfaction
13
The slide uses Kaplan-Meier survival curves to demonstrate clinical efficacy.analyze_data
Open slide detailBeat · Satisfaction
14
The slide uses a horizontal bar chart format to map drug indications against disease progression stages.present_solution
Open slide detailBeat · Satisfaction
15
front_matter
Open slide detailBeat · Satisfaction
16
The slide uses a timeline structure to demonstrate long-term innovation and market presence.establish_context
Open slide detailBeat · Satisfaction
17
The slide uses a three-column layout to define strategic pillars, each supported by specific tactical focus areas represented by circular icons.present_framework
Open slide detailBeat · Satisfaction
18
The slide uses a Kaplan-Meier curve to demonstrate clinical efficacy, supported by epidemiological data on the right.analyze_data
Open slide detailBeat · Satisfaction
19
Includes a waterfall chart showing clinical response data and a list of upcoming trial milestones.summarize
Open slide detailBeat · Satisfaction
20
The slide uses a matrix-like layout to map clinical trial phases and treatment strategies against patient segments.plan_implementation
Open slide detailBeat · Satisfaction
21
The slide uses a three-column layout to compare different drug assets in the pipeline.compare_peers
Open slide detailBeat · ActionLoop · Cost Of Inaction
22
The slide uses a grid layout to map drug indications against patient segments and treatment lines.present_solution
Open slide detailBeat · ActionLoop · Cost Of Inaction
23
front_matter
Open slide detailBeat · ActionLoop · Cost Of Inaction
24
The slide uses Kaplan-Meier survival curves to demonstrate efficacy in two distinct clinical settings.analyze_data
Open slide detailBeat · ActionLoop · Cost Of Inaction
25
The slide uses a stacked bar chart to show revenue growth over time, segmented by region, alongside key performance indicators for US and Ex-US markets.analyze_data
Open slide detailBeat · ActionLoop · Cost Of Inaction
26
The slide uses color-coding on the map to represent the three waves of the global rollout.plan_implementation
Open slide detailBeat · ActionLoop · Cost Of Inaction
27
Data from ELEVATE-TN Phase III trial presented at ASCO 2021.analyze_data
Open slide detailBeat · ActionLoop · Cost Of Inaction
28
Source: abstract 7500, ASCO 2021.analyze_data
Open slide detailBeat · ActionLoop · Cost Of Inaction
29
The slide uses a three-column layout to categorize drug development projects by their biological target and therapeutic approach.present_solution
Open slide detailBeat · Action
30
The slide uses a matrix format to map drug targets/mechanisms against disease indications.plan_implementation
Open slide detailBeat · Action
31
The slide serves as a transition or introduction to a new section of the presentation.front_matter
Open slide detailBeat · Action
32
The slide uses a circular flywheel-style diagram to categorize therapeutic approaches (Immune engagers, Cell therapy, etc.) against tumor-killing mechanisms.present_framework
Open slide detailBeat · Action
33
The slide uses a cell cycle diagram for DDR, a triangular framework for IO, and a list of modalities.present_solution
Open slide detailBeat · Action
34
The slide uses a three-column layout to present distinct clinical trial results for three different drug programs.analyze_data
Open slide detailBeat · Action
35
Slide 35 of a presentation, likely from AstraZeneca.analyze_data
Open slide detailBeat · Action
36
The slide uses a three-column layout to categorize different drug discovery and development technologies.present_solution
Open slide detailBeat · Action
37
The slide uses a color-coded legend to map drug candidates to specific oncology research areas.other
Open slide detailBeat · Action
38
The slide uses a contrast between a yellow table for early-stage pipeline and a dark purple/grey section for late-stage/marketed products.present_solution
Open slide detailBeat · Action
39
Includes instructions for both digital webinar interface and phone dial-in.state_next_steps
Open slide detailBeat · Action
40
other
Open slide detailBeat · Action